These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17138865)

  • 1. Anti-inflammatory effects of 4-phenyl-3-butenoic acid and 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid methyl ester, potential inhibitors of neuropeptide bioactivation.
    Bauer JD; Sunman JA; Foster MS; Thompson JR; Ogonowski AA; Cutler SJ; May SW; Pollock SH
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1171-7. PubMed ID: 17138865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiinflammatory and analgesic activity of an inhibitor of neuropeptide amidation.
    Ogonowski AA; May SW; Moore AB; Barrett LT; O'Bryant CL; Pollock SH
    J Pharmacol Exp Ther; 1997 Feb; 280(2):846-53. PubMed ID: 9023299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amidation inhibitors 4-phenyl-3-butenoic acid and 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid methyl ester are novel HDAC inhibitors with anti-tumorigenic properties.
    Ali A; Burns TJ; Lucrezi JD; May SW; Green GR; Matesic DF
    Invest New Drugs; 2015 Aug; 33(4):827-34. PubMed ID: 26065689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of JNK and p38 MAPK phosphorylation by 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid methyl ester and 4-phenyl-butenoic acid decreases substance P-induced TNF-α upregulation in macrophages.
    Lucrezi JD; Burns TJ; Matesic DF; Oldham CD; May SW
    Int Immunopharmacol; 2014 Jul; 21(1):44-50. PubMed ID: 24746749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular and endothelial actions of inhibitors of substance P amidation.
    Abou-Mohamed GA; Huang J; Oldham CD; Taylor TA; Jin L; Caldwell RB; May SW; Caldwell RW
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):871-80. PubMed ID: 10836720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of the transformed phenotype and inhibition of peptidylglycine alpha-monooxygenase in Ras-transformed cells by 4-phenyl-3-butenoic acid.
    Sunman JA; Foster MS; Folse SL; May SW; Matesic DF
    Mol Carcinog; 2004 Dec; 41(4):231-46. PubMed ID: 15468302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo inhibition of peptidylglycine-alpha-hydroxylating monooxygenase by 4-phenyl-3-butenoic acid.
    Mueller GP; Driscoll WJ; Eipper BA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1331-6. PubMed ID: 10454511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological evaluation of 1-(carboxymethyl)-3,5-diphenyl-2-methylbenzene, a novel arylacetic acid with potential anti-inflammatory properties.
    Cutler SJ; DeWitt Blanton C; Akin DT; Steinberg FB; Moore AB; Lott JA; Price TC; May SW; Pollock SH
    Inflamm Res; 1998 Jul; 47(7):316-24. PubMed ID: 9719496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship.
    Hayashi S; Sumi Y; Ueno N; Murase A; Takada J
    Biochem Pharmacol; 2011 Oct; 82(7):755-68. PubMed ID: 21741371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of COX-1/COX-2 selectivity and potency of a new class of COX-2 inhibitors.
    Gierse J; Nickols M; Leahy K; Warner J; Zhang Y; Cortes-Burgos L; Carter J; Seibert K; Masferrer J
    Eur J Pharmacol; 2008 Jun; 588(1):93-8. PubMed ID: 18457826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterisation of the somatostatin analogue TT-232: effects on neurogenic and non-neurogenic inflammation and neuropathic hyperalgesia.
    Pintér E; Helyes Z; Németh J; Pórszász R; Pethö G; Thán M; Kéri G; Horváth A; Jakab B; Szolcsányi J
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):142-50. PubMed ID: 12122501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents.
    Khalil NA; Ahmed EM; Mohamed KO; Nissan YM; Zaitone SA
    Bioorg Med Chem; 2014 Apr; 22(7):2080-9. PubMed ID: 24631365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
    Tewari AK; Singh VP; Yadav P; Gupta G; Singh A; Goel RK; Shinde P; Mohan CG
    Bioorg Chem; 2014 Oct; 56():8-15. PubMed ID: 24893208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study.
    Abdel-Aziz AA; ElTahir KE; Asiri YA
    Eur J Med Chem; 2011 May; 46(5):1648-55. PubMed ID: 21388719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of FK881(ASP6537), a novel potent and selective cyclooxygenase-1 inhibitor.
    Imanishi J; Morita Y; Yoshimi E; Kuroda K; Masunaga T; Yamagami K; Kuno M; Hamachi E; Aoki S; Takahashi F; Nakamura K; Miyata S; Ohkubo Y; Mutoh S
    Biochem Pharmacol; 2011 Oct; 82(7):746-54. PubMed ID: 21745460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Simultaneous and sequential inhibition of the arachidonic acid cascade by inhibitors of phospholipase A2, cyclooxygenase and lipoxygenases in carrageenan edema and adjuvant arthritis in the rat].
    Bekemeier H; Hirschelmann R; Ramanampison ML; Pantović D
    Pharmazie; 1986 Jun; 41(6):406-8. PubMed ID: 3094043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats.
    Matsushita M; Masaki M; Yagi Y; Tanaka T; Wakitani K
    Inflamm Res; 1997 Nov; 46(11):461-6. PubMed ID: 9427067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1,2,4-triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti-inflammatory and analgesic agents.
    Banerjee AG; Das N; Shengule SA; Srivastava RS; Shrivastava SK
    Eur J Med Chem; 2015 Aug; 101():81-95. PubMed ID: 26117820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and anti-inflammatory evaluation of a series of novel amino acid-binding 1,5-diarylpyrazole derivatives.
    Li MH; Yin LL; Cai MJ; Zhang WY; Huang Y; Wang X; Zhu XZ; Shen JK
    Acta Pharmacol Sin; 2005 Jul; 26(7):865-72. PubMed ID: 15960895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.